Mylan NV (NASDAQ:MYL)

19.42
Delayed Data
As of May 20
 -0.22 / -1.12%
Today’s Change
19.14
Today|||52-Week Range
42.50
-29.12%
Year-to-Date
Theravance Biopharma and Mylan Present Additional YUPELRI?? (revefenacin) Phase 3 Data...
May 20 / PR NewswirePRN - Paid Partner Content
Here's Why Generic-Drug Manufacturers Were Down Monday
May 14 / MotleyFool.com - Paid Partner Content
Theravance Biopharma and Mylan Present Additional YUPELRI?? (revefenacin) Phase 3 Data...
May 20 / PR NewswirePRN - Paid Partner Content
Generic Drugmakers Face Antitrust Suit Alleging Price Fixing
May 14 / Zacks.com - Paid Partner Content
Mylan to Host Investor Day on July 31, 2019 in New York City
May 17 / PR NewswirePRN - Paid Partner Content
Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates
May 08 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer
May 15 / Zacks.com - Paid Partner Content
Company News For May 8, 2019
May 08 / Zacks.com - Paid Partner Content
AbbVie Settles Humira Litigation With Boehringer Ingelheim
May 15 / Zacks.com - Paid Partner Content
Mylan N.V. (MYL) Q1 2019 Earnings Call Transcript
May 07 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close19.64
Today’s open19.64
Day’s range19.14 - 19.77
Volume6,743,574
Average volume (3 months)6,299,039
Market cap$10.1B
Data as of 4:00pm ET, 05/20/2019

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-6.27%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio42.2
Price/Sales1.24
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-2.04-3.07%
IONSIonis Pharmaceutical...+0.06+0.09%
SRPTSarepta Therapeutics...-4.10-3.37%
BHCValeant Pharmaceutic...-0.83-3.31%
Data as of 4:02pm ET, 05/20/2019

Financials

Next reporting dateAugust 8, 2019
EPS forecast (this quarter)$0.95
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts